XGN — EXAGEN INC.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1274737 ·
Last close
$3.76
Market Cap
$95.93M
52W High
$9.22
52W Low
$2.59
ADV30
667,114
Next earnings
2026-11-10
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | 19,941,000 | 12,217,000 | -1,722,000 | -3,196,000 | 51,935,000 | 24,588,000 | 39,719,000 |
| Mar 2026 | 17,306,000 | 10,205,000 | -3,414,000 | -3,967,000 | 51,957,000 | 21,513,000 | 37,525,000 |
| Dec 2025 | 16,631,000 | 9,206,000 | -4,975,000 | -4,673,000 | 58,022,000 | 32,220,000 | 40,573,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-12,017,000
Investing CF
$-1,002,000
Financing CF
$5,459,000
CapEx
$-1,011,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.75
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-327,781,000
Inventory
—
Receivables
$11,481,000
ST Investments
—
EBIT TTM
$-13,125,000
Pretax Income TTM
$-18,124,000
Interest Exp TTM
$4,999,000
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$72,295,000
EBITDA
$-12,035,000
Free Cash Flow
$-1,557,000
Enterprise Value
$105,655,008
Total Cash
$28,092,000
Total Debt
$28,761,000
Shares Out
25,513,497
Trailing EPS
$-0.76
Book Value
$0.54
ROE
-113.9%
ROA
-15.4%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 66,575,000 | -14,070,000 | -19,951,000 | 58,022,000 | 40,573,000 | 17,449,000 | -13,625,000 |
| Dec 2024 | 55,641,000 | -13,636,000 | -15,115,000 | 44,689,000 | 35,149,000 | 9,540,000 | -13,279,000 |
| Dec 2023 | 52,548,000 | -22,837,000 | -23,689,000 | 56,944,000 | 34,250,000 | 22,694,000 | -14,462,000 |
| Dec 2022 | 45,563,000 | -40,545,000 | -47,387,000 | 86,221,000 | 43,761,000 | 42,460,000 | -32,144,000 |
TTM Snapshot
Revenues TTM
$71,122,000
NetIncome TTM
$-18,923,000
OpCashFlow TTM
—
Assets (Latest)
$51,935,000
Forward EPS
$-0.50
Max Pain — expiry 2027-04-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $7.50 · spot: $3.90 · call volume: 25 · put volume: 1
Expected Move to 2027-04-16:
±$2.90
(74.36%) —
implied range
$1.00 –
$6.80
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BDSX | BIODESIX INC | $98.47M | $8.88 | — |
| LFMD | LifeMD, Inc. | $86.76M | $1.79 | — |
| PARK | Park Dental Partners, Inc. | $107.16M | $19.36 | — |
| BNR | Burning Rock Biotech Ltd | $110.17M | $12.50 | — |
| SERA | SERA PROGNOSTICS, INC. | $77.60M | $2.00 | — |
News headlines (Yahoo Finance, 1h cache)
Exagen Inc (XGN) (Q3 2026) Earnings Call Highlights: Record Q3 Revenue, 14th Straight ASP Gain, ...
2026-11-11 09:03 · Yahoo
Exagen (XGN) Q3 2026 Earnings Call Transcript
2026-11-10 20:28 · Yahoo
What Exagen (XGN) Said on Its Q3 Earnings Call
2026-11-10 19:15 · Yahoo
Exagen Inc. (XGN) Reports Q3 Loss, Tops Revenue Estimates
2026-11-10 12:45 · Yahoo
Exagen Inc. Reports Third Quarter 2026 Financial Results
2026-11-10 12:30 · Yahoo
Exagen Inc. to Participate in Upcoming Investor Conferences
2026-10-29 13:00 · Yahoo
Exagen to Announce Third Quarter Financial Results on November 10, 2026
2026-10-27 13:00 · Yahoo
Exagen (XGN) Q2 2026 Earnings Call Transcript
2026-08-11 17:31 · Yahoo
Exagen (XGN) Stock Gets Fair Value Boost As Analysts Weigh Growth And Execution
2026-08-06 04:32 · Yahoo
Exagen Reports Record Second-Quarter 2026 Revenue and Raises Full-Year Guidance
2026-08-04 15:28 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.